Found 124 hits with Last Name = 'peng' and Initial = 'a' Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Fatty acid-binding protein, adipocyte
(Rattus norvegicus) | BDBM50212873
(((2'-(5-ETHYL-3,4-DIPHENYL-1H-PYRAZOL-1-YL)-3-BIPH...)Show SMILES CCc1c(c(nn1-c1ccccc1-c1cccc(OCC(O)=O)c1)-c1ccccc1)-c1ccccc1 Show InChI InChI=1S/C31H26N2O3/c1-2-27-30(22-12-5-3-6-13-22)31(23-14-7-4-8-15-23)32-33(27)28-19-10-9-18-26(28)24-16-11-17-25(20-24)36-21-29(34)35/h3-20H,2,21H2,1H3,(H,34,35) | PDB
MMDB
Reactome pathway
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet 
| Purchase
CHEMBL
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Patents
| PDB
Article
PubMed
| 29 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sichuan University
Curated by ChEMBL
| Assay Description
Inhibition of rat ap2 by fluorescent 1,8-anilino-8-naphthalene sulfonate assay |
Eur J Med Chem 52: 70-81 (2012)
Article DOI: 10.1016/j.ejmech.2012.03.006
BindingDB Entry DOI: 10.7270/Q26H4JD5 |
More data for this
Ligand-Target Pair | 
3D Structure (crystal) |
Fatty acid-binding protein, adipocyte
(Rattus norvegicus) | BDBM50381857
(CHEMBL2023268)Show InChI InChI=1S/C18H14FNO2/c19-16-7-3-1-5-14(16)12-20-11-13(9-10-18(21)22)15-6-2-4-8-17(15)20/h1-11H,12H2,(H,21,22)/b10-9+ | PDB
MMDB
Reactome pathway
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| 33 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sichuan University
Curated by ChEMBL
| Assay Description
Inhibition of rat ap2 by fluorescent 1,8-anilino-8-naphthalene sulfonate assay |
Eur J Med Chem 52: 70-81 (2012)
Article DOI: 10.1016/j.ejmech.2012.03.006
BindingDB Entry DOI: 10.7270/Q26H4JD5 |
More data for this
Ligand-Target Pair | |
cGMP-specific 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM14390
(5-[2-ethoxy-5-(4-methyl-1-piperazinylsulfonyl)phen...)Show SMILES CCCc1nn(C)c2c1nc([nH]c2=O)-c1cc(ccc1OCC)S(=O)(=O)N1CCN(C)CC1 Show InChI InChI=1S/C22H30N6O4S/c1-5-7-17-19-20(27(4)25-17)22(29)24-21(23-19)16-14-15(8-9-18(16)32-6-2)33(30,31)28-12-10-26(3)11-13-28/h8-9,14H,5-7,10-13H2,1-4H3,(H,23,24,29) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
KEGG
MMDB
PC cid
PC sid
PDB
UniChem
Patents
Similars
| MMDB
PDB
Article
PubMed
| n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences
Curated by ChEMBL
| Assay Description
Inhibition of phosphodiesterase 5 isolated from human platelets |
Bioorg Med Chem Lett 15: 2790-4 (2005)
Article DOI: 10.1016/j.bmcl.2005.03.102
BindingDB Entry DOI: 10.7270/Q2JW8FNG |
More data for this
Ligand-Target Pair |
3D Structure (crystal) |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521506
(CHEMBL4551114)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2F)-c2c[nH]c3ncnc(N)c23)no1 Show InChI InChI=1S/C20H20FN7O2/c1-20(2,3)14-7-15(28-30-14)27-19(29)26-13-5-4-10(6-12(13)21)11-8-23-18-16(11)17(22)24-9-25-18/h4-9H,1-3H3,(H3,22,23,24,25)(H2,26,27,28,29) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521476
(CHEMBL4517711)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2c[nH]c3ncnc(N)c23)no1 Show InChI InChI=1S/C20H21N7O2/c1-20(2,3)14-8-15(27-29-14)26-19(28)25-12-6-4-11(5-7-12)13-9-22-18-16(13)17(21)23-10-24-18/h4-10H,1-3H3,(H3,21,22,23,24)(H2,25,26,27,28) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521496
(CHEMBL4435457)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cn(CCC#N)c3ncnc(N)c23)no1 Show InChI InChI=1S/C23H24N8O2/c1-23(2,3)17-11-18(30-33-17)29-22(32)28-15-7-5-14(6-8-15)16-12-31(10-4-9-24)21-19(16)20(25)26-13-27-21/h5-8,11-13H,4,10H2,1-3H3,(H2,25,26,27)(H2,28,29,30,32) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521471
(CHEMBL4439404)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cn(CC=C)c3ncnc(N)c23)no1 Show InChI InChI=1S/C23H25N7O2/c1-5-10-30-12-16(19-20(24)25-13-26-21(19)30)14-6-8-15(9-7-14)27-22(31)28-18-11-17(32-29-18)23(2,3)4/h5-9,11-13H,1,10H2,2-4H3,(H2,24,25,26)(H2,27,28,29,31) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
MCE
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521494
(CHEMBL4557634)Show SMILES Cn1cc(-c2ccc(NC(=O)Nc3cc(on3)C(C)(C)C)cc2)c2c(N)ncnc12 Show InChI InChI=1S/C21H23N7O2/c1-21(2,3)15-9-16(27-30-15)26-20(29)25-13-7-5-12(6-8-13)14-10-28(4)19-17(14)18(22)23-11-24-19/h5-11H,1-4H3,(H2,22,23,24)(H2,25,26,27,29) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521498
(CHEMBL4572972)Show SMILES CCn1cc(-c2ccc(NC(=O)Nc3cc(on3)C(C)(C)C)cc2)c2c(N)ncnc12 Show InChI InChI=1S/C22H25N7O2/c1-5-29-11-15(18-19(23)24-12-25-20(18)29)13-6-8-14(9-7-13)26-21(30)27-17-10-16(31-28-17)22(2,3)4/h6-12H,5H2,1-4H3,(H2,23,24,25)(H2,26,27,28,30) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50300690
(1-(5-Tert-Butyl-1,2-Oxazol-3-Yl)-3-(4-{7-[2-(Morph...)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cn3c(n2)sc2cc(OCCN4CCOCC4)ccc32)no1 Show InChI InChI=1S/C29H32N6O4S/c1-29(2,3)25-17-26(33-39-25)32-27(36)30-20-6-4-19(5-7-20)22-18-35-23-9-8-21(16-24(23)40-28(35)31-22)38-15-12-34-10-13-37-14-11-34/h4-9,16-18H,10-15H2,1-3H3,(H2,30,32,33,36) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
PC cid
PC sid
PDB
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 7.40 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
cGMP-specific 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50166817
(3-[2-Ethoxy-5-(4-ethyl-piperazine-1-sulfonyl)-phen...)Show SMILES CCOc1ccc(cc1-c1nc2c(nc3cccc(C)n23)c(=O)[nH]1)S(=O)(=O)N1CCN(CC)CC1 Show InChI InChI=1S/C24H28N6O4S/c1-4-28-11-13-29(14-12-28)35(32,33)17-9-10-19(34-5-2)18(15-17)22-26-23-21(24(31)27-22)25-20-8-6-7-16(3)30(20)23/h6-10,15H,4-5,11-14H2,1-3H3,(H,26,27,31) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences
Curated by ChEMBL
| Assay Description
Inhibition of phosphodiesterase 5 isolated from human platelets |
Bioorg Med Chem Lett 15: 2790-4 (2005)
Article DOI: 10.1016/j.bmcl.2005.03.102
BindingDB Entry DOI: 10.7270/Q2JW8FNG |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521477
(CHEMBL4572804)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cn(CCCN3CCOCC3)c3ncnc(N)c23)no1 Show InChI InChI=1S/C27H34N8O3/c1-27(2,3)21-15-22(33-38-21)32-26(36)31-19-7-5-18(6-8-19)20-16-35(25-23(20)24(28)29-17-30-25)10-4-9-34-11-13-37-14-12-34/h5-8,15-17H,4,9-14H2,1-3H3,(H2,28,29,30)(H2,31,32,33,36) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521489
(CHEMBL4440175)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cn(CC#N)c3ncnc(N)c23)no1 Show InChI InChI=1S/C22H22N8O2/c1-22(2,3)16-10-17(29-32-16)28-21(31)27-14-6-4-13(5-7-14)15-11-30(9-8-23)20-18(15)19(24)25-12-26-20/h4-7,10-12H,9H2,1-3H3,(H2,24,25,26)(H2,27,28,29,31) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521505
(CHEMBL4441629)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cn(CCN3CCNCC3)c3ncnc(N)c23)no1 Show InChI InChI=1S/C26H33N9O2/c1-26(2,3)20-14-21(33-37-20)32-25(36)31-18-6-4-17(5-7-18)19-15-35(13-12-34-10-8-28-9-11-34)24-22(19)23(27)29-16-30-24/h4-7,14-16,28H,8-13H2,1-3H3,(H2,27,29,30)(H2,31,32,33,36) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521487
(CHEMBL4459941)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cn(CC#C)c3ncnc(N)c23)no1 Show InChI InChI=1S/C23H23N7O2/c1-5-10-30-12-16(19-20(24)25-13-26-21(19)30)14-6-8-15(9-7-14)27-22(31)28-18-11-17(32-29-18)23(2,3)4/h1,6-9,11-13H,10H2,2-4H3,(H2,24,25,26)(H2,27,28,29,31) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
cGMP-specific 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50166820
(3-[2-Ethoxy-5-(4-methyl-piperazine-1-sulfonyl)-phe...)Show SMILES CCOc1ccc(cc1-c1nc2c(nc3cccc(C)n23)c(=O)[nH]1)S(=O)(=O)N1CCN(C)CC1 Show InChI InChI=1S/C23H26N6O4S/c1-4-33-18-9-8-16(34(31,32)28-12-10-27(3)11-13-28)14-17(18)21-25-22-20(23(30)26-21)24-19-7-5-6-15(2)29(19)22/h5-9,14H,4,10-13H2,1-3H3,(H,25,26,30) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences
Curated by ChEMBL
| Assay Description
Inhibition of phosphodiesterase 5 isolated from human platelets |
Bioorg Med Chem Lett 15: 2790-4 (2005)
Article DOI: 10.1016/j.bmcl.2005.03.102
BindingDB Entry DOI: 10.7270/Q2JW8FNG |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521480
(CHEMBL4441875)Show SMILES CCCn1cc(-c2ccc(NC(=O)Nc3cc(on3)C(C)(C)C)cc2)c2c(N)ncnc12 Show InChI InChI=1S/C23H27N7O2/c1-5-10-30-12-16(19-20(24)25-13-26-21(19)30)14-6-8-15(9-7-14)27-22(31)28-18-11-17(32-29-18)23(2,3)4/h6-9,11-13H,5,10H2,1-4H3,(H2,24,25,26)(H2,27,28,29,31) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
cGMP-specific 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50166821
(3-[2-Ethoxy-5-(4-isopropyl-piperazine-1-sulfonyl)-...)Show SMILES CCOc1ccc(cc1-c1nc2c(nc3cccc(C)n23)c(=O)[nH]1)S(=O)(=O)N1CCN(CC1)C(C)C Show InChI InChI=1S/C25H30N6O4S/c1-5-35-20-10-9-18(36(33,34)30-13-11-29(12-14-30)16(2)3)15-19(20)23-27-24-22(25(32)28-23)26-21-8-6-7-17(4)31(21)24/h6-10,15-16H,5,11-14H2,1-4H3,(H,27,28,32) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences
Curated by ChEMBL
| Assay Description
Inhibition of phosphodiesterase 5 isolated from human platelets |
Bioorg Med Chem Lett 15: 2790-4 (2005)
Article DOI: 10.1016/j.bmcl.2005.03.102
BindingDB Entry DOI: 10.7270/Q2JW8FNG |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521482
(CHEMBL4541344)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cn(CCCCO)c3ncnc(N)c23)no1 Show InChI InChI=1S/C24H29N7O3/c1-24(2,3)18-12-19(30-34-18)29-23(33)28-16-8-6-15(7-9-16)17-13-31(10-4-5-11-32)22-20(17)21(25)26-14-27-22/h6-9,12-14,32H,4-5,10-11H2,1-3H3,(H2,25,26,27)(H2,28,29,30,33) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521490
(CHEMBL4454804)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2F)-c2cn(CC=C)c3ncnc(N)c23)no1 Show InChI InChI=1S/C23H24FN7O2/c1-5-8-31-11-14(19-20(25)26-12-27-21(19)31)13-6-7-16(15(24)9-13)28-22(32)29-18-10-17(33-30-18)23(2,3)4/h5-7,9-12H,1,8H2,2-4H3,(H2,25,26,27)(H2,28,29,30,32) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521478
(CHEMBL4475375)Show SMILES CN(C)CCn1cc(-c2ccc(NC(=O)Nc3cc(on3)C(C)(C)C)cc2)c2c(N)ncnc12 Show InChI InChI=1S/C24H30N8O2/c1-24(2,3)18-12-19(30-34-18)29-23(33)28-16-8-6-15(7-9-16)17-13-32(11-10-31(4)5)22-20(17)21(25)26-14-27-22/h6-9,12-14H,10-11H2,1-5H3,(H2,25,26,27)(H2,28,29,30,33) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521497
(CHEMBL4461531)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2F)-c2cn(CC#N)c3ncnc(N)c23)no1 Show InChI InChI=1S/C22H21FN8O2/c1-22(2,3)16-9-17(30-33-16)29-21(32)28-15-5-4-12(8-14(15)23)13-10-31(7-6-24)20-18(13)19(25)26-11-27-20/h4-5,8-11H,7H2,1-3H3,(H2,25,26,27)(H2,28,29,30,32) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521479
(CHEMBL4435360)Show SMILES CC(C)n1cc(-c2ccc(NC(=O)Nc3cc(on3)C(C)(C)C)cc2)c2c(N)ncnc12 Show InChI InChI=1S/C23H27N7O2/c1-13(2)30-11-16(19-20(24)25-12-26-21(19)30)14-6-8-15(9-7-14)27-22(31)28-18-10-17(32-29-18)23(3,4)5/h6-13H,1-5H3,(H2,24,25,26)(H2,27,28,29,31) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521493
(CHEMBL4515336)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cn(CCN3CCOCC3)c3ncnc(N)c23)no1 Show InChI InChI=1S/C26H32N8O3/c1-26(2,3)20-14-21(32-37-20)31-25(35)30-18-6-4-17(5-7-18)19-15-34(9-8-33-10-12-36-13-11-33)24-22(19)23(27)28-16-29-24/h4-7,14-16H,8-13H2,1-3H3,(H2,27,28,29)(H2,30,31,32,35) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521507
(CHEMBL4575519)Show SMILES COCCn1cc(-c2ccc(NC(=O)Nc3cc(on3)C(C)(C)C)cc2)c2c(N)ncnc12 Show InChI InChI=1S/C23H27N7O3/c1-23(2,3)17-11-18(29-33-17)28-22(31)27-15-7-5-14(6-8-15)16-12-30(9-10-32-4)21-19(16)20(24)25-13-26-21/h5-8,11-13H,9-10H2,1-4H3,(H2,24,25,26)(H2,27,28,29,31) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521504
(CHEMBL4472511)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2F)-c2cn(CCC#N)c3ncnc(N)c23)no1 Show InChI InChI=1S/C23H23FN8O2/c1-23(2,3)17-10-18(31-34-17)30-22(33)29-16-6-5-13(9-15(16)24)14-11-32(8-4-7-25)21-19(14)20(26)27-12-28-21/h5-6,9-12H,4,8H2,1-3H3,(H2,26,27,28)(H2,29,30,31,33) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
P04972/P11541/P16586/P22571/P23439/Q95142
(Bos taurus-Bos taurus (Bovine)) | BDBM14390
(5-[2-ethoxy-5-(4-methyl-1-piperazinylsulfonyl)phen...)Show SMILES CCCc1nn(C)c2c1nc([nH]c2=O)-c1cc(ccc1OCC)S(=O)(=O)N1CCN(C)CC1 Show InChI InChI=1S/C22H30N6O4S/c1-5-7-17-19-20(27(4)25-17)22(29)24-21(23-19)16-14-15(8-9-18(16)32-6-2)33(30,31)28-12-10-26(3)11-13-28/h8-9,14H,5-7,10-13H2,1-4H3,(H,23,24,29) | PDB
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
KEGG
MMDB
PC cid
PC sid
PDB
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 25 | n/a | n/a | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences
Curated by ChEMBL
| Assay Description
Inhibition of phosphodiesterase 6 isolated from bovine retina |
Bioorg Med Chem Lett 15: 2790-4 (2005)
Article DOI: 10.1016/j.bmcl.2005.03.102
BindingDB Entry DOI: 10.7270/Q2JW8FNG |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521474
(CHEMBL4526888)Show SMILES CC(C)(C)OC(=O)n1cc(-c2ccc(NC(=O)Nc3cc(on3)C(C)(C)C)cc2)c2c(N)ncnc12 Show InChI InChI=1S/C25H29N7O4/c1-24(2,3)17-11-18(31-36-17)30-22(33)29-15-9-7-14(8-10-15)16-12-32(23(34)35-25(4,5)6)21-19(16)20(26)27-13-28-21/h7-13H,1-6H3,(H2,26,27,28)(H2,29,30,31,33) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 25 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521502
(CHEMBL4539069)Show SMILES CC#CCn1cc(-c2ccc(NC(=O)Nc3cc(on3)C(C)(C)C)cc2)c2c(N)ncnc12 Show InChI InChI=1S/C24H25N7O2/c1-5-6-11-31-13-17(20-21(25)26-14-27-22(20)31)15-7-9-16(10-8-15)28-23(32)29-19-12-18(33-30-19)24(2,3)4/h7-10,12-14H,11H2,1-4H3,(H2,25,26,27)(H2,28,29,30,32) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521500
(CHEMBL4438587)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cn(CCN3CCN(CC3)S(C)(=O)=O)c3ncnc(N)c23)no1 Show InChI InChI=1S/C27H35N9O4S/c1-27(2,3)21-15-22(33-40-21)32-26(37)31-19-7-5-18(6-8-19)20-16-35(25-23(20)24(28)29-17-30-25)12-9-34-10-13-36(14-11-34)41(4,38)39/h5-8,15-17H,9-14H2,1-4H3,(H2,28,29,30)(H2,31,32,33,37) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521472
(CHEMBL4569015)Show SMILES CC(=C)Cn1cc(-c2ccc(NC(=O)Nc3cc(on3)C(C)(C)C)cc2)c2c(N)ncnc12 Show InChI InChI=1S/C24H27N7O2/c1-14(2)11-31-12-17(20-21(25)26-13-27-22(20)31)15-6-8-16(9-7-15)28-23(32)29-19-10-18(33-30-19)24(3,4)5/h6-10,12-13H,1,11H2,2-5H3,(H2,25,26,27)(H2,28,29,30,32) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521483
(CHEMBL4586009)Show SMILES CCN(CC)C(=O)n1cc(-c2ccc(NC(=O)Nc3cc(on3)C(C)(C)C)cc2)c2c(N)ncnc12 Show InChI InChI=1S/C25H30N8O3/c1-6-32(7-2)24(35)33-13-17(20-21(26)27-14-28-22(20)33)15-8-10-16(11-9-15)29-23(34)30-19-12-18(36-31-19)25(3,4)5/h8-14H,6-7H2,1-5H3,(H2,26,27,28)(H2,29,30,31,34) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 31 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521491
(CHEMBL4532475)Show SMILES COCCn1cc(-c2ccc(NC(=O)Nc3cc(on3)C(C)(C)C)c(F)c2)c2c(N)ncnc12 Show InChI InChI=1S/C23H26FN7O3/c1-23(2,3)17-10-18(30-34-17)29-22(32)28-16-6-5-13(9-15(16)24)14-11-31(7-8-33-4)21-19(14)20(25)26-12-27-21/h5-6,9-12H,7-8H2,1-4H3,(H2,25,26,27)(H2,28,29,30,32) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 32 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521481
(CHEMBL4529106)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cn(C3CCCC3)c3ncnc(N)c23)no1 Show InChI InChI=1S/C25H29N7O2/c1-25(2,3)19-12-20(31-34-19)30-24(33)29-16-10-8-15(9-11-16)18-13-32(17-6-4-5-7-17)23-21(18)22(26)27-14-28-23/h8-14,17H,4-7H2,1-3H3,(H2,26,27,28)(H2,29,30,31,33) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 32 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
cGMP-specific 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50166822
(6-Bromo-3-[2-ethoxy-5-(4-methyl-piperazine-1-sulfo...)Show SMILES CCOc1ccc(cc1-c1nc2c(nc3ccc(Br)c(C)n23)c(=O)[nH]1)S(=O)(=O)N1CCN(C)CC1 Show InChI InChI=1S/C23H25BrN6O4S/c1-4-34-18-7-5-15(35(32,33)29-11-9-28(3)10-12-29)13-16(18)21-26-22-20(23(31)27-21)25-19-8-6-17(24)14(2)30(19)22/h5-8,13H,4,9-12H2,1-3H3,(H,26,27,31) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 33 | n/a | n/a | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences
Curated by ChEMBL
| Assay Description
Inhibition of phosphodiesterase 5 isolated from human platelets |
Bioorg Med Chem Lett 15: 2790-4 (2005)
Article DOI: 10.1016/j.bmcl.2005.03.102
BindingDB Entry DOI: 10.7270/Q2JW8FNG |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521499
(CHEMBL4449006)Show SMILES CCCCn1cc(-c2ccc(NC(=O)Nc3cc(on3)C(C)(C)C)cc2)c2c(N)ncnc12 Show InChI InChI=1S/C24H29N7O2/c1-5-6-11-31-13-17(20-21(25)26-14-27-22(20)31)15-7-9-16(10-8-15)28-23(32)29-19-12-18(33-30-19)24(2,3)4/h7-10,12-14H,5-6,11H2,1-4H3,(H2,25,26,27)(H2,28,29,30,32) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521484
(CHEMBL4553847)Show SMILES CCOCCn1cc(-c2ccc(NC(=O)Nc3cc(on3)C(C)(C)C)cc2)c2c(N)ncnc12 Show InChI InChI=1S/C24H29N7O3/c1-5-33-11-10-31-13-17(20-21(25)26-14-27-22(20)31)15-6-8-16(9-7-15)28-23(32)29-19-12-18(34-30-19)24(2,3)4/h6-9,12-14H,5,10-11H2,1-4H3,(H2,25,26,27)(H2,28,29,30,32) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 37 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521485
(CHEMBL4591906)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cn(CCC=C)c3ncnc(N)c23)no1 Show InChI InChI=1S/C24H27N7O2/c1-5-6-11-31-13-17(20-21(25)26-14-27-22(20)31)15-7-9-16(10-8-15)28-23(32)29-19-12-18(33-30-19)24(2,3)4/h5,7-10,12-14H,1,6,11H2,2-4H3,(H2,25,26,27)(H2,28,29,30,32) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 38 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
cGMP-specific 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50166824
(3-[2-Ethoxy-5-(4-methyl-piperazine-1-sulfonyl)-phe...)Show SMILES CCOc1ccc(cc1-c1nc2c(nc3cccc(CC)n23)c(=O)[nH]1)S(=O)(=O)N1CCN(C)CC1 Show InChI InChI=1S/C24H28N6O4S/c1-4-16-7-6-8-20-25-21-23(30(16)20)26-22(27-24(21)31)18-15-17(9-10-19(18)34-5-2)35(32,33)29-13-11-28(3)12-14-29/h6-10,15H,4-5,11-14H2,1-3H3,(H,26,27,31) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 38 | n/a | n/a | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences
Curated by ChEMBL
| Assay Description
Inhibition of phosphodiesterase 5 isolated from human platelets |
Bioorg Med Chem Lett 15: 2790-4 (2005)
Article DOI: 10.1016/j.bmcl.2005.03.102
BindingDB Entry DOI: 10.7270/Q2JW8FNG |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521503
(CHEMBL4483045)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2F)-c2cn(CC#C)c3ncnc(N)c23)no1 Show InChI InChI=1S/C23H22FN7O2/c1-5-8-31-11-14(19-20(25)26-12-27-21(19)31)13-6-7-16(15(24)9-13)28-22(32)29-18-10-17(33-30-18)23(2,3)4/h1,6-7,9-12H,8H2,2-4H3,(H2,25,26,27)(H2,28,29,30,32) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 46 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
cGMP-specific 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50166818
(3-[2-Ethoxy-5-(4-methyl-piperazine-1-sulfonyl)-phe...)Show SMILES CCOc1ccc(cc1-c1nc2c(nc3ccc(C)cn23)c(=O)[nH]1)S(=O)(=O)N1CCN(C)CC1 Show InChI InChI=1S/C23H26N6O4S/c1-4-33-18-7-6-16(34(31,32)28-11-9-27(3)10-12-28)13-17(18)21-25-22-20(23(30)26-21)24-19-8-5-15(2)14-29(19)22/h5-8,13-14H,4,9-12H2,1-3H3,(H,25,26,30) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 48 | n/a | n/a | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences
Curated by ChEMBL
| Assay Description
Inhibition of phosphodiesterase 5 isolated from human platelets |
Bioorg Med Chem Lett 15: 2790-4 (2005)
Article DOI: 10.1016/j.bmcl.2005.03.102
BindingDB Entry DOI: 10.7270/Q2JW8FNG |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521492
(CHEMBL4439044)Show SMILES CCOCCn1cc(-c2ccc(NC(=O)Nc3cc(on3)C(C)(C)C)c(F)c2)c2c(N)ncnc12 Show InChI InChI=1S/C24H28FN7O3/c1-5-34-9-8-32-12-15(20-21(26)27-13-28-22(20)32)14-6-7-17(16(25)10-14)29-23(33)30-19-11-18(35-31-19)24(2,3)4/h6-7,10-13H,5,8-9H2,1-4H3,(H2,26,27,28)(H2,29,30,31,33) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 49 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521473
(CHEMBL4558160)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2F)-c2cn(CCC=C)c3ncnc(N)c23)no1 Show InChI InChI=1S/C24H26FN7O2/c1-5-6-9-32-12-15(20-21(26)27-13-28-22(20)32)14-7-8-17(16(25)10-14)29-23(33)30-19-11-18(34-31-19)24(2,3)4/h5,7-8,10-13H,1,6,9H2,2-4H3,(H2,26,27,28)(H2,29,30,31,33) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 51 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521488
(CHEMBL4553033)Show SMILES CCC#CCn1cc(-c2ccc(NC(=O)Nc3cc(on3)C(C)(C)C)cc2)c2c(N)ncnc12 Show InChI InChI=1S/C25H27N7O2/c1-5-6-7-12-32-14-18(21-22(26)27-15-28-23(21)32)16-8-10-17(11-9-16)29-24(33)30-20-13-19(34-31-20)25(2,3)4/h8-11,13-15H,5,12H2,1-4H3,(H2,26,27,28)(H2,29,30,31,33) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 64 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521501
(CHEMBL4457542)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cn(CCCC=C)c3ncnc(N)c23)no1 Show InChI InChI=1S/C25H29N7O2/c1-5-6-7-12-32-14-18(21-22(26)27-15-28-23(21)32)16-8-10-17(11-9-16)29-24(33)30-20-13-19(34-31-20)25(2,3)4/h5,8-11,13-15H,1,6-7,12H2,2-4H3,(H2,26,27,28)(H2,29,30,31,33) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 69 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521486
(CHEMBL4442278)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cn(CCCCC=C)c3ncnc(N)c23)no1 Show InChI InChI=1S/C26H31N7O2/c1-5-6-7-8-13-33-15-19(22-23(27)28-16-29-24(22)33)17-9-11-18(12-10-17)30-25(34)31-21-14-20(35-32-21)26(2,3)4/h5,9-12,14-16H,1,6-8,13H2,2-4H3,(H2,27,28,29)(H2,30,31,32,34) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 70 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
cGMP-specific 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50166816
(3-[2-Ethoxy-5-(4-methyl-piperazine-1-sulfonyl)-phe...)Show SMILES CCOc1ccc(cc1-c1nc2c(nc3c(C)cccn23)c(=O)[nH]1)S(=O)(=O)N1CCN(C)CC1 Show InChI InChI=1S/C23H26N6O4S/c1-4-33-18-8-7-16(34(31,32)28-12-10-27(3)11-13-28)14-17(18)20-25-22-19(23(30)26-20)24-21-15(2)6-5-9-29(21)22/h5-9,14H,4,10-13H2,1-3H3,(H,25,26,30) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 80 | n/a | n/a | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences
Curated by ChEMBL
| Assay Description
Inhibition of phosphodiesterase 5 isolated from human platelets |
Bioorg Med Chem Lett 15: 2790-4 (2005)
Article DOI: 10.1016/j.bmcl.2005.03.102
BindingDB Entry DOI: 10.7270/Q2JW8FNG |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521495
(CHEMBL4551816)Show SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cn(Cc3ccccc3)c3ncnc(N)c23)no1 Show InChI InChI=1S/C27H27N7O2/c1-27(2,3)21-13-22(33-36-21)32-26(35)31-19-11-9-18(10-12-19)20-15-34(14-17-7-5-4-6-8-17)25-23(20)24(28)29-16-30-25/h4-13,15-16H,14H2,1-3H3,(H2,28,29,30)(H2,31,32,33,35) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 86 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50521475
(CHEMBL4533761)Show SMILES CCCCCCn1cc(-c2ccc(NC(=O)Nc3cc(on3)C(C)(C)C)cc2)c2c(N)ncnc12 Show InChI InChI=1S/C26H33N7O2/c1-5-6-7-8-13-33-15-19(22-23(27)28-16-29-24(22)33)17-9-11-18(12-10-17)30-25(34)31-21-14-20(35-32-21)26(2,3)4/h9-12,14-16H,5-8,13H2,1-4H3,(H2,27,28,29)(H2,30,31,32,34) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | 105 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Inhibition of recombinant human FLT3 (564 to end residues) using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma-33P]-ATP by s... |
J Med Chem 62: 4158-4173 (2019)
Article DOI: 10.1021/acs.jmedchem.9b00223
BindingDB Entry DOI: 10.7270/Q2QJ7MPQ |
More data for this
Ligand-Target Pair | |
cGMP-specific 3',5'-cyclic phosphodiesterase
(Homo sapiens (Human)) | BDBM50166827
(3-[2-Ethoxy-5-(4-methyl-piperazine-1-sulfonyl)-phe...)Show SMILES CCOc1ccc(cc1-c1nc2c(nc3cc(C)ccn23)c(=O)[nH]1)S(=O)(=O)N1CCN(C)CC1 Show InChI InChI=1S/C23H26N6O4S/c1-4-33-18-6-5-16(34(31,32)28-11-9-27(3)10-12-28)14-17(18)21-25-22-20(23(30)26-21)24-19-13-15(2)7-8-29(19)22/h5-8,13-14H,4,9-12H2,1-3H3,(H,25,26,30) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 112 | n/a | n/a | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences
Curated by ChEMBL
| Assay Description
Inhibition of phosphodiesterase 5 isolated from human platelets |
Bioorg Med Chem Lett 15: 2790-4 (2005)
Article DOI: 10.1016/j.bmcl.2005.03.102
BindingDB Entry DOI: 10.7270/Q2JW8FNG |
More data for this
Ligand-Target Pair | |
Search and Browse
